Brainstorm Cell Therapeutics Inc. (BCLI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Brainstorm Cell Therapeut...

    NASDAQ: BCLI · Real-Time Price · USD
    0.69
    -0.01 (-1.43%)
    At close: Sep 26, 2025, 10:33 AM

    Brainstorm Cell Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 849K n/a n/a n/a
    Cost of Revenue
    		 240K 265K 285K 260K
    Gross Profit
    		 849K -265K -285K -260K
    Operating Income
    		 -11.69M -21.44M -24.82M -24.54M
    Interest Income
    		 n/a n/a 545K 82K
    Pretax Income
    		 11.62M -17.19M -24.28M -24.46M
    Net Income
    		 11.62M -17.19M -24.28M -24.46M
    Selling & General & Admin
    		 7.04M 10.69M 10.87M 9.3M
    Research & Development
    		 4.41M 10.48M 13.96M 15.23M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 11.45M 21.17M 24.82M 24.54M
    Interest Expense
    		 77K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 11.69M 21.44M 24.82M 24.54M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 5.31M 3.84M 2.45M 2.42M
    Shares Outstanding (Diluted)
    		 5.31M 3.84M 2.45M 2.42M
    EPS (Basic)
    		 2.19 -4.48 -9.93 -10.09
    EPS (Diluted)
    		 2.19 -4.48 -9.93 -10.09
    EBITDA
    		 -11.31M -16.93M -23.99M -24.28M
    EBIT
    		 -11.55M -17.19M -24.28M -24.46M
    Depreciation & Amortization
    		 240K 265K 285K 260K

    Add to Watchlist